Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 613641, 4 pages
http://dx.doi.org/10.1155/2014/613641
Case Report

Hyperacute Rejection of a Living Unrelated Kidney Graft

1Department of General and Visceral Surgery, University of Freiburg, Hugstetter Straße 55, 79106 Freiburg im Breisgau, Germany
2Department of General Surgery, University Hospital Lübeck, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
3Institute of Pathology, University of Freiburg, Breisacher Straße 115a, 79106 Freiburg im Breisgau, Germany
4Department of Transfusion Medicine, University of Freiburg, Hugstetter Straße 55, 79106 Freiburg im Breisgau, Germany
5Department of Nephrology, University of Freiburg, Hugstetter Straße 55, 79106 Freiburg im Breisgau, Germany

Received 1 July 2014; Revised 26 August 2014; Accepted 26 August 2014; Published 17 September 2014

Academic Editor: Tobias Keck

Copyright © 2014 Dietlind Tittelbach-Helmrich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Ghasemian, J. A. Light, C. B. Currier et al., “The significance of the IgG anti-B-cell crossmatch on renal transplant outcome,” Clinical Transplantation, vol. 11, no. 5, part 2, pp. 485–487, 1997. View at Google Scholar · View at Scopus
  2. J. R. Moraes and P. Stastny, “A new antigen system expressed in human endothelial cells,” Journal of Clinical Investigation, vol. 60, no. 2, pp. 449–454, 1977. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Jordan, H. K. Yap, R. S. Sakai, P. Alfonso, and M. Fitchman, “Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with A negative monocyte crossmatch,” Transplantation, vol. 46, no. 4, pp. 585–587, 1988. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Sumitran-Karuppan, G. Tyden, F. Reinholt, U. Berg, and E. Moller, “Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells,” Transplant Immunology, vol. 5, no. 4, pp. 321–327, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Hocher, T. Slowinski, I. Hauser et al., “Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients,” Thrombosis and Haemostasis, vol. 87, no. 2, pp. 194–198, 2002. View at Google Scholar · View at Scopus
  6. R. P. Wüthrich, S. Cicvara-Muzar, C. Booy, and F. E. Maly, “Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss,” Transplantation, vol. 72, no. 3, pp. 549–550, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Ekberg, P. J. Svensson, M. Simanaitis, and B. Dahlbäck, “Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection,” Transplantation, vol. 69, no. 8, pp. 1577–1581, 2000. View at Google Scholar